GO:0030299 intestinal cholesterol absorption: Transport Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030299 intestinal cholesterol absorption is the biological process by which cholesterol is taken up from the small intestine into the blood.
• The process is genetically regulated and involves multiple transporters, including NPC1L1, ABCG5/ABCG8, and SR-BI.
• Dietary and pharmacological factors, such as plant sterols and ezetimibe, can modulate intestinal cholesterol absorption.
• Cholesterol absorption is linked to immune responses and lipid metabolism, with recent evidence connecting T cell cholesterol transport to dietary lipid absorption.
• Studying this process requires integrated approaches from transporter assays to CRISPR-based gene editing and animal models.
• Dysregulation of intestinal cholesterol absorption contributes to hypercholesterolemia and cardiovascular disease risk.
Description
Intestinal cholesterol absorption is a critical biological process that determines how dietary and biliary cholesterol enter the bloodstream. This process, annotated as GO:0030299, is defined as the uptake of cholesterol into the blood by absorption from the small intestine. It is a key step in whole-body cholesterol homeostasis and a target for interventions aimed at lowering plasma cholesterol levels. Understanding the molecular players and regulatory mechanisms is essential for developing therapies against cardiovascular disease. The process involves a series of events at the enterocyte brush border, intracellular transport, and basolateral secretion, with several transporters and enzymes playing distinct roles. Recent research has highlighted the interplay between intestinal cholesterol absorption and immune function, underscoring its broader physiological significance. This article provides a comprehensive overview of GO:0030299, integrating authoritative definitions with published literature to support researchers in the field.
intestinal cholesterol absorption At A Glance
| GO ID | GO:0030299 |
|---|---|
| GO term | intestinal cholesterol absorption |
| Ontology | biological_process |
| Synonym | none |
| Major function | Uptake of cholesterol into the blood by absorption from the small intestine |
| Related transporters | NPC1L1, ABCG5, ABCG8, SR-BI, CD36 |
| Key tissues | Small intestine (enterocytes) |
| Regulatory factors | Dietary sterols, ezetimibe, genetic variants |
What Is GO:0030299?
GO:0030299 intestinal cholesterol absorption is the biological process in which cholesterol is taken up from the lumen of the small intestine into the bloodstream. This definition encompasses the movement of cholesterol across the enterocyte, from the apical membrane to the basolateral side, and its eventual entry into circulation. The process is distinct from cholesterol synthesis and is a major determinant of plasma cholesterol levels.
Why Is intestinal cholesterol absorption Important in Cell Biology?
Intestinal cholesterol absorption is a central node in lipid metabolism and a major contributor to plasma cholesterol levels. Its dysregulation is implicated in hypercholesterolemia, atherosclerosis, and cardiovascular disease. Moreover, recent studies have revealed an unexpected link between cholesterol absorption and intestinal immune responses, suggesting broader roles in health and disease. Targeting this process offers therapeutic opportunities for managing dyslipidemias.
• Determines the efficiency of dietary and biliary cholesterol uptake, influencing whole-body cholesterol balance.
• Genetic variations in transporters such as NPC1L1 and ABCG5/ABCG8 affect absorption efficiency and disease risk.
• Pharmacological inhibition of cholesterol absorption (e.g., ezetimibe) lowers LDL cholesterol.
• Plant sterols and stanols reduce cholesterol absorption by competing for uptake mechanisms.
• Links to immune function: T cell cholesterol transport can modulate intestinal immune responses.
• Provides a target for functional foods and nutraceuticals aimed at cardiovascular risk reduction.
• Altered absorption contributes to sitosterolemia and other lipid disorders.
• Model systems for studying absorption include intestinal cell lines and knockout mice.
• Understanding species differences in cholesterol absorption is important for translational research.
• Emerging evidence suggests crosstalk with gut microbiota and bile acid metabolism.
What Happens During intestinal cholesterol absorption?
Luminal Solubilization and Micelle Formation
In simple terms: Cholesterol must be dissolved in bile salt micelles before it can be absorbed.
Dietary and biliary cholesterol are hydrophobic and require solubilization by bile salts and phospholipids to form mixed micelles in the intestinal lumen. This step is essential for presenting cholesterol to the enterocyte brush border. Factors such as bile acid composition and dietary fat content influence micelle formation and subsequent absorption efficiency.
Apical Uptake by Enterocytes
In simple terms: Cholesterol enters the intestinal cell through specific transporter proteins.
The apical membrane of enterocytes expresses several proteins that facilitate cholesterol uptake. NPC1L1 (Niemann-Pick C1-like 1) is a key sterol transporter that mediates the majority of intestinal cholesterol absorption. Other proteins, such as SR-BI (scavenger receptor class B type I) and CD36, may also contribute to uptake, although their roles are less well defined. The process is energy-dependent and subject to regulation by dietary and pharmacological factors.
Intracellular Transport and Esterification
In simple terms: Inside the cell, cholesterol is moved and modified for packaging.
Once inside the enterocyte, cholesterol is transported to the endoplasmic reticulum (ER) where it can be esterified by ACAT2 (acyl-CoA:cholesterol acyltransferase 2). Esterification converts cholesterol to cholesteryl esters, which are then packaged into chylomicrons for secretion. The intracellular trafficking involves multiple proteins, including NPC1L1 and possibly annexins. This step is critical for maintaining cellular cholesterol homeostasis and preventing toxicity.
Basolateral Secretion into Lymph
In simple terms: Cholesterol leaves the cell and enters the lymphatic system.
Cholesteryl esters and free cholesterol are assembled into chylomicrons, which are secreted across the basolateral membrane into the lymphatic system. This process requires the action of microsomal triglyceride transfer protein (MTTP) and other factors. From lymph, chylomicrons enter the bloodstream, delivering cholesterol to peripheral tissues. The secretion step is regulated by the availability of lipids and apolipoproteins.
Efflux and Regulation by ABC Transporters
In simple terms: Some cholesterol is pumped back out of the cell to limit absorption.
Enterocytes express the heterodimeric transporters ABCG5 and ABCG8, which pump plant sterols and excess cholesterol back into the intestinal lumen. This efflux mechanism is crucial for preventing the accumulation of potentially toxic sterols. Mutations in ABCG5 or ABCG8 cause sitosterolemia, a disorder characterized by hyperabsorption of plant sterols. The balance between uptake and efflux determines net cholesterol absorption.
Key Genes Involved in GO:0030299 intestinal cholesterol absorption
The following genes and proteins are central to intestinal cholesterol absorption, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NPC1L1 | Apical cholesterol transporter; mediates uptake | Target of ezetimibe; knockout mice show reduced absorption |
| ABCG5 | Heterodimeric sterol efflux pump | Mutations cause sitosterolemia; regulates plant sterol absorption |
| ABCG8 | Heterodimeric sterol efflux pump | Mutations cause sitosterolemia; regulates plant sterol absorption |
| SR-BI | Scavenger receptor; facilitates cholesterol uptake | May contribute to HDL-mediated cholesterol absorption |
| CD36 | Fatty acid and cholesterol transporter | Potential role in cholesterol uptake; under investigation |
| ACAT2 | Esterifies cholesterol in enterocytes | Knockout reduces cholesteryl ester formation and absorption |
| MTTP | Assembles chylomicrons | Essential for basolateral secretion; mutations cause abetalipoproteinemia |
| ApoB-48 | Structural apolipoprotein of chylomicrons | Required for chylomicron assembly and secretion |
| ApoA-IV | Modulates lipid absorption and chylomicron size | May influence absorption efficiency |
| LXR | Nuclear receptor regulating ABCG5/ABCG8 | Activation increases efflux and reduces absorption |
| FXR | Nuclear receptor regulating bile acid metabolism | Indirectly affects cholesterol absorption |
| PPARα | Regulates lipid metabolism | May influence intestinal cholesterol handling |
| SREBP-2 | Regulates cholesterol synthesis and uptake | Feedback regulation of NPC1L1 |
| HNF4α | Transcription factor regulating enterocyte genes | Controls expression of transporters |
| CDX2 | Intestinal transcription factor | Regulates enterocyte differentiation and transporter expression |
| GATA4 | Transcription factor | Modulates intestinal gene expression |
| TTC39B | Regulates cholesterol absorption | Genetic variants associated with HDL levels |
| NPC1 | Intracellular cholesterol trafficking | Related to NPC1L1; involved in lysosomal cholesterol transport |
How Is intestinal cholesterol absorption Regulated?
Intestinal cholesterol absorption is regulated at multiple levels. Transcriptional control of NPC1L1 and ABCG5/ABCG8 is mediated by nuclear receptors such as LXR and SREBP-2. Dietary factors, including plant sterols and stanols, can competitively inhibit cholesterol uptake. Hormonal signals and bile acids also modulate the process. Recent evidence suggests that immune cells, such as T cells, can influence intestinal cholesterol transport, linking immune responses to lipid absorption.
intestinal cholesterol absorption and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NPC1L1 | Hypercholesterolemia; cardiovascular disease | Knockout mouse; overexpression in intestinal cell lines |
| ABCG5 | Sitosterolemia; premature atherosclerosis | Knockout mouse; point mutation models |
| ABCG8 | Sitosterolemia; premature atherosclerosis | Knockout mouse; point mutation models |
| ACAT2 | Dyslipidemia; altered cholesterol absorption | Knockout mouse; overexpression studies |
| MTTP | Abetalipoproteinemia; fat malabsorption | Knockout mouse; knock-in of patient mutations |
Hypercholesterolemia and Cardiovascular Disease
Increased intestinal cholesterol absorption contributes to elevated plasma LDL cholesterol, a major risk factor for atherosclerosis and cardiovascular disease. Genetic variants in NPC1L1 and ABCG5/ABCG8 are associated with altered absorption efficiency and cardiovascular risk. Therapeutic strategies targeting absorption, such as ezetimibe, have proven effective in lowering LDL cholesterol.
Sitosterolemia
Sitosterolemia is a rare autosomal recessive disorder caused by mutations in ABCG5 or ABCG8, leading to hyperabsorption of plant sterols and premature atherosclerosis. This condition highlights the critical role of efflux transporters in limiting intestinal sterol absorption.
Metabolic Syndrome and Diabetes
Altered intestinal cholesterol absorption has been implicated in metabolic syndrome and type 2 diabetes. Insulin resistance may affect enterocyte lipid handling, although the mechanisms are not fully understood. Targeting absorption pathways could offer therapeutic benefits in these conditions.
Immune Regulation
Recent studies have uncovered a link between intestinal cholesterol absorption and immune responses. T cell cholesterol transport can modulate dietary lipid absorption, suggesting a bidirectional relationship between immunity and lipid metabolism. This opens new avenues for research into inflammatory bowel diseases and metabolic inflammation.
From intestinal cholesterol absorption-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate intestinal cholesterol absorption? | Knockout mouse or intestinal cell line (e.g., Caco-2) |
| What is the effect of a specific point mutation in NPC1L1? | Point-mutation knock-in mouse or CRISPR-edited cell line |
| Can overexpression of ABCG5 reduce absorption? | Transgenic overexpression mouse or lentiviral overexpression in enterocytes |
| How does a tagged transporter localize in enterocytes? | Tagged knock-in (e.g., GFP-NPC1L1) in mice or cells |
| What is the role of a candidate gene in a high-throughput screen? | CRISPR library screening in intestinal organoids |
| Does a genetic variant affect absorption efficiency? | Knock-in of human variant in mouse model |
How to Study the intestinal cholesterol absorption Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Dual-isotope absorption assay | Fractional cholesterol absorption | In vivo studies in mice or humans |
| Fecal sterol balance | Net cholesterol absorption and synthesis | Clinical and animal studies |
| Caco-2 cell uptake assay | Cellular cholesterol uptake | Mechanistic studies of transporters |
| RNA-seq | Transcriptional changes | Identifying regulated genes |
| CRISPR knockout screening | Gene function in absorption | High-throughput discovery |
| Fluorescence microscopy | Protein localization | Trafficking studies |
| Intravital imaging | Real-time absorption | Dynamic processes in live animals |
| Chylomicron secretion assay | Basolateral secretion | Lipoprotein assembly studies |
In Vivo Absorption Assays
Intestinal cholesterol absorption can be measured in vivo using dual-isotope methods or fecal sterol balance studies in animal models. These techniques allow quantification of fractional absorption and are considered gold standards.
Cell Culture Models
Caco-2 and other intestinal cell lines are widely used to study cholesterol uptake and transport at the cellular level. These models permit mechanistic studies of transporter function and regulation.
Genomic and Transcriptomic Approaches
RNA-seq and single-cell transcriptomics can identify genes and pathways differentially expressed in enterocytes during cholesterol absorption. CRISPR screening combined with transcriptomics can uncover novel regulators.
Imaging and Localization
Fluorescence microscopy and live-cell imaging of tagged transporters (e.g., GFP-NPC1L1) reveal subcellular localization and trafficking dynamics. Intravital imaging can assess absorption in real time.
How CRISPR Can Be Used to Study GO:0030299 intestinal cholesterol absorption
Knockout
CRISPR knockout of candidate genes such as NPC1L1 or ABCG5 in intestinal cell lines or mouse models can definitively test their role in cholesterol absorption. Knockout mice for NPC1L1 show reduced absorption and are protected from diet-induced hypercholesterolemia.
Point Mutation
Introducing specific point mutations (e.g., in NPC1L1 or ABCG8) via CRISPR can model human genetic variants associated with altered absorption. This approach helps dissect the functional impact of single-nucleotide polymorphisms.
Knock-in
Knock-in of tagged versions of transporters (e.g., GFP-NPC1L1) allows visualization and biochemical isolation of the protein in its native context. Knock-in of human disease mutations into mouse orthologs can create accurate models of sitosterolemia.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of genes like ABCG5 can increase efflux and reduce cholesterol absorption. Overexpression studies in Caco-2 cells can reveal dose-dependent effects on transport.
How EDITGENE Supports intestinal cholesterol absorption Research
Researchers studying intestinal cholesterol absorption-related genes often need to determine whether a candidate gene is causally involved in the process or is merely a biomarker. Functional validation through precise genome editing is essential to establish causality and to model human genetic variants.
Contact EDITGENE today to design your custom CRISPR model for intestinal cholesterol absorption research.
Frequently Asked Questions About intestinal cholesterol absorption
What is GO:0030299 intestinal cholesterol absorption?
GO:0030299 is a Gene Ontology biological process term defined as the uptake of cholesterol into the blood by absorption from the small intestine.
What genes are involved in intestinal cholesterol absorption?
Key genes include NPC1L1, ABCG5, ABCG8, SR-BI, CD36, ACAT2, and MTTP, among others.
How is intestinal cholesterol absorption regulated?
It is regulated by nuclear receptors (LXR, SREBP-2), dietary sterols, and hormones, as well as by immune cells.
What diseases are associated with altered intestinal cholesterol absorption?
Hypercholesterolemia, cardiovascular disease, sitosterolemia, and metabolic syndrome are linked to altered absorption.
What is the role of NPC1L1 in cholesterol absorption?
NPC1L1 is a key apical transporter that mediates the majority of intestinal cholesterol uptake and is the target of ezetimibe.
How can I study intestinal cholesterol absorption in the lab?
Methods include in vivo isotope assays, Caco-2 cell uptake studies, CRISPR screens, and animal models.
What is sitosterolemia and how does it relate to cholesterol absorption?
Sitosterolemia is a disorder caused by mutations in ABCG5 or ABCG8, leading to hyperabsorption of plant sterols.
Can CRISPR be used to study cholesterol absorption genes?
Yes, CRISPR knockout, knock-in, and overexpression models are powerful tools to dissect gene function in absorption.
What are the current treatments targeting intestinal cholesterol absorption?
Ezetimibe and plant sterols/stanols are used to reduce cholesterol absorption.
How does intestinal cholesterol absorption affect the immune system?
Recent evidence shows that T cell cholesterol transport can modulate intestinal immune responses and dietary lipid absorption.
Conclusion
Intestinal cholesterol absorption (GO:0030299) is a fundamental biological process with profound implications for cardiovascular health and metabolic disease. The integration of genetic, molecular, and pharmacological approaches has elucidated key transporters and regulatory pathways. Continued research using advanced CRISPR models and high-throughput screening will further unravel the complexities of this process and identify new therapeutic targets.
References
- 1. Gao Y et al.. 2025. T cell cholesterol transport links intestinal immune responses to dietary lipid absorption.. Science 390(6769):eadt4169 PMID: 41066556
- 2. Paalvast Y et al.. 2017. Developments in intestinal cholesterol transport and triglyceride absorption.. Curr Opin Lipidol 28(3):248-254 PMID: 28338522
- 3. Yamanashi Y et al.. 2017. Transporters for the Intestinal Absorption of Cholesterol, Vitamin E, and Vitamin K.. J Atheroscler Thromb 24(4):347-359 PMID: 28100881
- 4. Ikeda I. 2015. Factors affecting intestinal absorption of cholesterol and plant sterols and stanols.. J Oleo Sci 64(1):9-18 PMID: 25742922
- 5. Cohn JS et al.. 2010. Reduction in intestinal cholesterol absorption by various food components: mechanisms and implications.. Atheroscler Suppl 11(1):45-8 PMID: 20439167
- 6. Lichtenstein AH. 1990. Intestinal cholesterol metabolism.. Ann Med 22(1):49-52 PMID: 2184845
- 7. Wang DQ. 2003. New concepts of mechanisms of intestinal cholesterol absorption.. Ann Hepatol 2(3):113-21 PMID: 15115962
- 8. Lammert F et al.. 2005. New insights into the genetic regulation of intestinal cholesterol absorption.. Gastroenterology 129(2):718-34 PMID: 16083725
